BiotechTube
Home/SonoVascular/Jacob Ruprecht
JR

Jacob Ruprecht

VP of Engineering

SonoVascular

Therapeutic Areas

CardiovascularVascular Diseases

SonoVascular Pipeline

DrugIndicationPhase
SonoThrombectomy™ SystemVenous Thromboembolism (VTE) / Deep Vein Thrombosis (DVT)Early Feasibility / First-in-Human

Leadership Team at SonoVascular

DE
Daniel Estay
Founder & CEO
LH
Luke Harada
Chief Operating Officer
CN
Craig Nichols
VP of Clinical & RA/QA
BS
Bill Starling
Board Member
View full SonoVascular profile